Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾Ï¿¡¼­ Cyclooxygenase-2 ¹ßÇöÀÇ ¿¹ÈÄÀÎÀÚÀû °¡Ä¡ Prognostic Value of Elevated Cyclooxygenase-2 Expression in Breast Cancer

´ëÇÑ¿Ü°úÇÐȸÁö 2003³â 65±Ç 5È£ p.377 ~ 381
¼³Áø¿ø, ¿À±â±Ù, ±è½ÂÀÏ, ¹ÚÂùÈç, ¹ÚöÀç,
¼Ò¼Ó »ó¼¼Á¤º¸
¼³Áø¿ø (  ) 
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

¿À±â±Ù (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è½ÂÀÏ (  ) 
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹ÚÂùÈç (  ) 
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹ÚöÀç (  ) 
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose: Cyclooxygenase-2 (Cox-2) is the rate-limiting enzyme in the conversion of arachidonic acid to prostaglandins and can be induced by various agents such as growth factors and tumor promoters. Cox-2 contributes to carcinogenesis and tumor growth. This study was performed to demonstrate the correlation between elevated expression of Cox-2 and pathologic factors in breast cancer.
Methods: Cox-2 expression was analyzed immunohistochemically in paraffin-embedded tumor samples from 40 patients with breast cancer. Cox-2 expression was defined as negative or positive. The correlation between Cox-2 expression and pathologic factors (tumor size, axillary lymph node metastasis, TNM stage and histologic grade) was analyzed.
Results: Cox-2 was highly expressed in proportion to tumor size, but the difference was not significant (P>0.05). High Cox-2 expression was observed in the presence of axillary lymph node metastasis and TNM stage ¥², but was not significant (P>0.05). The Cox-2 expression rate was significantly associated with high histologic grade (¥°: 42.9%, ¥±:50.0%, ¥²:80.0%) (P=0.046).
Conclusion: Elevated levels of Cox-2 expression were associated with large tumor size, presence of axillary lymph node metastasis, high TNM stage and high histologic grade, and can therefore be a possible marker for poor prognosis. Due to the small number of cases, we couldn¢¥t confirm the statistical significance except in terms of histologic grade. Further prospective studies with a large number of cases are required.

Å°¿öµå

À¯¹æ¾Ï;Cycloxygenase-2;¿¹ÈÄÀÎÀÚ;Breast cancer;Prognostic factors

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS